Found: 3
Select item for more details and to access through your institution.
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 3, p. 1, doi. 10.1002/dad2.12456
- By:
- Publication type:
- Article
Plasma pTau181 and biomarker combinations to identify Alzheimer´s disease at any stage along the AD continuum compared with both controls and non‐AD dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077504
- By:
- Publication type:
- Article
Thimet Oligopeptidase is a potential CSF biomarker for Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.065528
- By:
- Publication type:
- Article